1-(4-methoxyphenyl)pyridinium has been researched along with euk-134 in 1 studies
| Studies (1-(4-methoxyphenyl)pyridinium) | Trials (1-(4-methoxyphenyl)pyridinium) | Recent Studies (post-2010) (1-(4-methoxyphenyl)pyridinium) | Studies (euk-134) | Trials (euk-134) | Recent Studies (post-2010) (euk-134) |
|---|---|---|---|---|---|
| 55 | 0 | 1 | 87 | 0 | 39 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baudry, M; Fonck, C | 1 |
1 other study(ies) available for 1-(4-methoxyphenyl)pyridinium and euk-134
| Article | Year |
|---|---|
Rapid reduction of ATP synthesis and lack of free radical formation by MPP+ in rat brain synaptosomes and mitochondria.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine Triphosphate; Animals; Antioxidants; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cyclic N-Oxides; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Free Radicals; In Vitro Techniques; Male; Mazindol; Mitochondria; Neostriatum; Nitrogen Oxides; Organometallic Compounds; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Rotenone; Salicylates; Subcellular Fractions; Synaptosomes; Uncoupling Agents | 2003 |